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Abstract
Background: Large thrombus burdens in ectatic coronary arteries that remain after aspiration thrombectomy can
negatively impact outcomes following percutaneous coronary interventions in patients with acute myocardial
infarction.
Case presentation: A 53-year-old man presented with ST-segment elevation myocardial infarction (STEMI).
Coronary angiography revealed an ectatic right coronary artery (RCA) that was completely occluded in the mid
portion by a large amount of thrombus. Catheter-directed intracoronary thrombolysis with alteplase led to recovery
of coronary blood flow, which multiple attempts of aspiration thrombectomy had failed to achieve. Coronary
angiography 9 days later showed good blood flow and insignificant stenosis remaining in the RCA; this had
completely resolved in 6 months’ follow-up coronary angiography.
Conclusion: Catheter-directed intracoronary thrombolysis can be performed effectively and safely when repeat
aspiration thrombectomy fails to produce satisfactory coronary reperfusion in STEMI patients with large thrombus
burdens in ectatic coronary arteries.
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Background
Intracoronary thrombosis in patients with ST-segment
elevation myocardial infarction (STEMI) can cause distal
embolization, no-reflow phenomena and stent throm-
bosis, and increase the risk of adverse cardiac events and
death following primary percutaneous coronary inter-
ventions (PCIs) [1, 2]. Although the beneficial effect of
manual aspiration thrombectomy (MAT) during primary
PCIs is still open to debate, it is frequently employed as
a first-line therapy to reduce these adverse events [3].
However, there are no other effective options when
MAT delivers insufficient coronary blood flow, especially
in patients with large thrombus burdens. Here we report
a case of successful coronary reperfusion through a com-
bination of catheter-directed intracoronary thrombolysis
and MAT in STEMI caused by thrombotic occlusion of
an ectatic coronary artery.
Case presentation
A 53-year-old man presented in the emergency depart-
ment with sudden chest pain lasting for 30 min. He was
a 40-pack-year current smoker with high blood pressure
on no medication. Blood pressure was 160/110 mmHg
and pulse rate 60 beats/min. Electrocardiography
showed ST-segment elevations in leads II, III, and aVF
(Fig. 1a). Serum creatinine was 0.8 mg/dl and serum
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troponin I 0.01 ng/ml. Killip classification was class I.
Aspirin 300 mg and ticagrelor 180 mg were adminis-
tered, and coronary angiography (CAG) was performed
immediately under temporary ventricular pacing. CAG
revealed an ectatic right coronary artery (RCA) com-
pletely occluded by a large amount of thrombus in the
mid-portion (Fig. 2a). A bolus of unfractionated heparin
(8000 IU) and glycoprotein IIb/IIIa antagonist (abcixi-
mab, 0.25 mg/kg) was administered intravenously and
MAT was performed three times using a 6-Fr aspiration
catheter (Rebirth, Goodman Co. Ltd., Nagoya, Japan).
After red thrombi were aspirated, thrombolysis in
myocardial infarction (TIMI) grade 2 flow was achieved
but a large filling defect persisted in the mid portion of
the RCA, with distal embolization in the posterior
descending artery (PDA) (Fig. 2b). Intravascular ultra-
sound (IVUS) (Atlantis, Boston Scientific, Natick, MA)
revealed a ruptured plaque containing a large necrotic
core and a large amount of thrombus remaining in the
lesion. The external elastic membrane (EEM) diameter
and the luminal diameter of the normal adjacent prox-
imal segment of the occlusion were 7.5 mm and 6.5 mm,
respectively (Fig. 3a). The culprit lesion was 7.7 mm in
EEM diameter and 4.8 mm2 in minimal luminal area
Fig. 1 Electrocardiograms. a at admission. b after percutaneous coronary intervention
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(MLA) (Fig. 3b). Because stent apposition might be diffi-
cult in such a large vessel, we decided to perform
catheter-directed intracoronary thrombolysis using alte-
plase. The tip of a 2.7 Fr microcatheter (Progreat®, Ter-
umo, Somerset, NJ, USA) was placed on the culprit
lesion, and 5 mg of alteplase (Actilyse, Boehringer Ingel-
heim, Germany) in 5 mL normal saline was slowly ad-
ministered over five minutes through the microcatheter.
After 10 min, CAG showed improved coronary blood
flow from the TIMI grade 2 to 3 in the mid portion of
the RCA and from the TIMI grade 0 to 1 in the PDA,
with remaining thrombi in the mid portion (Fig. 2c). Be-
cause significant stenosis persisted, a 4.5 × 8 mm non-
compliant balloon (Quantum, Boston Scientific, Natick,
MA) was inflated up to 16 atm in the mid portion of the
RCA to disrupt the partially lysed thrombi. The lesion
was dilated after the balloon angioplasty; however TIMI
flow of the RCA appeared to be worsened (Fig. 2d).
Intracoronary thrombolysis was repeated in the same
manner. Blood flow improved to TIMI grade 3 and
IVUS showed increased MLA with remaining thrombi
(Fig. 3c). The chest pain was completely relieved and the
ST-segment elevation was resolved (Fig. 1b).
Intravenous infusion of the glycoprotein IIb/IIIa in-
hibitor was maintained for 12 h after PCI. Oral adminis-
tration of aspirin (100 mg/day), ticagrelor (180 mg/day),
rosuvastatin (20 mg/day), bisoprolol (1.25 mg/day), and
candesartan (8 mg/day) was continued. Low molecular
weight heparin (dalteparin 100 IU/kg every 12 h; Frag-
min®, Pfizer Inc., New York, NY) was administered sub-
cutaneously after the femoral sheath was removed. No
significant bleeding complications occurred after PCI.
CAG repeated 9 days after the PCI revealed TIMI grade
3 blood flow in the RCA and PDA, and insignificant
Fig. 2 Coronary angiography. a Thrombotic total occlusion of the mid portion of the right coronary artery (RCA) with TIMI grade 0 flow. b After
thrombus aspiration, a large filling defect remained due to extensive thrombus in the mid portion of the RCA with distal embolization in the
posterior descending artery (PDA). c After initial intracoronary thrombolysis and repeated thrombus aspiration, improvement of TIMI flow, distal
embolization, and residual thrombus at the mid portion of the RCA were noted. d After balloon angioplasty and second intracoronary
thrombolysis, the culprit stenotic lesion was dilated, but TIMI flow worsened with distal embolization. e On the ninth day after the primary
percutaneous intervention, TIMI flow was restored, but focal eccentric intermediate stenosis with some residual thrombus remained at the mid
portion of the RCA. f Six months after discharge, marked dissolution of the thrombus and only minimal stenosis at the mid portion of the RCA
was noted
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focal stenosis with a small amount of remaining
thrombus in the lesion (Fig. 2e). IVUS showed that the
MLA was 9.7 mm2 in the lesion (Fig. 3d) and the frac-
tional flow reserve measured under maximal hyperemia
was 0.98. Based on these assessments, we decided not to
perform any additional intervention. The patient was
discharged 12 days after PCI. CAG repeated 6 months
after PCI showed complete dissolution of the thrombi
and minimal remaining stenosis in the lesion with TIMI
3 blood flow in the RCA (Fig. 2f ).
Discussion and conclusions
Massive intracoronary thrombi are associated with
unsuccessful angiographic reperfusion and unfavorable
clinical outcomes [1, 4]. Unresolved intracoronary
thrombi can cause microvascular obstruction, known as
the no-reflow phenomenon, and result in reduced
myocardial perfusion at the microvascular level,
increased infarct size and higher mortality [5]. Although
there have been improvements in antiplatelet and anti-
coagulant regimens and technical advances in PCIs, intra-
coronary thrombus remains one of the most dreaded
enemies of interventional cardiologists. MAT is one of the
most frequently used thrombectomy methods in primary
PCIs, because the procedure is simple and the risk of vas-
cular injury and distal embolism is low. Clinical guidelines
also suggest that MAT is a reasonable approach when
intracoronary thrombi are encountered [3]. However,
studies have yielded inconsistent results in terms of its
benefits in primary PCI [6–8]. The TASTE trial showed
no benefits of MAT for mortality, re-hospitalization and
stent thrombosis [8]. More recently, Jolly et al. [7] also
reported that MAT did not reduce cardiovascular events,
whereas it increased stroke rate. This result may partly be
related to insufficient thrombus removal and inadequate
coronary blood flow recovery in cases with massive intra-
coronary thrombosis. Safe and feasible alternative strat-
egies are needed when MAT fails during primary PCI.
Fig. 3 Intravascular ultrasound (IVUS) findings. a Adjacent normal segment proximal to the occlusion site. The shortest EEM and luminal diameter
were 7.5 mm and 6.5 mm, respectively. b A ruptured plaque containing many necrotic components and a large amount of thrombus. The
diameter of the external elastic membrane was 7.7 mm. c After thrombus aspiration and intracoronary thrombolysis, intermediate stenosis with
remnant thrombi was noted. d On the ninth day after the primary percutaneous intervention, a minimal lumen area of about 9.73 mm2 with
plaque was noted
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Before coronary stents were much used, intracoronary
thrombolysis was used in patients with all types of cor-
onary artery disease [9, 10]. However, because studies
gave discouraging results [11] and primary PCI with
stent implantation became routine, intracoronary
thrombolysis was rarely used in clinical practice. In
recent years, intracoronary thrombolysis has regained
popularity as an adjuvant therapy for primary PCI, as
studies using different thrombolytic agents and
improved antiplatelet regimens showed it to be safe and
effective. Kelly et al. [12] reported that intracoronary
infusion of tenecteplase was safe and effective for coron-
ary flow recovery in patients with myocardial infarction.
More recently, Boscarelli et al. [13] found that adjuvant
intracoronary infusion of low dose tenecteplase and alte-
plase in STEMI significantly reduced the thrombi
remaining after MAT and improved coronary blood flow.
Several case reports of massive intracoronary thrombosis
also described successful recovery of coronary blood
flow after intracoronary thrombolysis using alteplase
[14] and tenecteplase [15].
We used the glycoprotein IIb/IIIa inhibitor after intra-
coronary thrombolysis, which may significantly increase
the risk of major bleeding events. However, the
thrombolytic agent doses used through intracoronary
routes are usually much lower than those used through
intravenous routes. Kelly et al. [12] also reported that
only 1 case of major bleeding (2.9%) among 34 patients
after intracoronary thrombolysis using tenectaplase,
which is similar to the major bleeding rates reported
regularly in acute coronary syndrome [16]. Moreover,
the majority of the patients (76%) in their study received
glycoprotein IIb/IIIa inhibitors simultaneously with
intracoronary thrombolysis.
In our case, a massive thrombotic occlusion occurred
in the ectatic RCA. Coronary ectasia is defined as a dif-
fuse dilation of a coronary artery to a diameter at least
1.5 times larger than normal coronary artery diameter
[17]. It is present in 1–5% of patients undergoing CAG
[18]. Various reperfusion strategies including MAT
alone, simple balloon angioplasty, pulse-spray thromb-
olysis, intracoronary thrombolysis and mesh-covered
stent implantation have been proposed in STEMI in
ectatic coronary arteries [19–21]. Several randomized
controlled trials have reported that rheolytic thrombec-
tomy was more effective than MAT in thrombus re-
moval and myocardial reperfusion in patients with
STEMI, although there were no differences in infarct
sizes and adverse cardiac events following PCI between
rheolytic thrombolysis and MAT [22, 23]. Simple bal-
loon angioplasty might increase the risk of distal
embolization after intracoronary thrombus is incom-
pletely removed. Prolonged intravenous heparin infusion
is a viable option for the remaining thrombus after MAT
in ectatic coronary arteries [24]. However, for ectatic
coronary arteries, because the sheer amount of
thrombus is massive and blood flow is slow, no single
strategy would be sufficient. In fact, we employed mul-
tiple strategies namely MAT, balloon angioplasty and
intracoronary thrombolysis during the PCI to achieve a
good immediate result. We think that the additional
anatomical and physiological information obtained by
IVUS and by measuring the fractional flow reserve
helped us avoid stent implantation, which could have led
to incomplete stent apposition. Self-expendable stents
have been introduced for patients with complex coron-
ary anatomy including aneurysmal dilation, which may
also be an alternative strategy to avoid difficulty in stent
apposition, as shown in our case [25].
In conclusion, catheter-directed intracoronary thromb-
olysis may be a safe and effective alternative reperfusion
strategy that may be selected when MAT alone fails to
achieve sufficient coronary blood flow in the culprit ves-
sel in STEMI associated with massive thrombosis in
ectatic coronary arteries.
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